Anti-tumor responses induced by chemokine CCL19 transfected into an ovarian carcinoma model via fiber-mutant adenovirus vector

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 6, 2005, Pages 1066-1070

  Gao, Jian Qing ^a,b   Sugita, Toshiki ^a   Kanagawa, Naoko ^a   Iida, Keisuke ^a   Okada, Naoki ^c   Mizuguchi, Hiroyuki ^a,d   Nakayama, Takashi ^e   Hayakawa, Takao ^f   Yoshie, Osamu ^e   Tsutsumi, Yasuo ^a,d   Mayumi, Tadanori ^a   Nakagawa, Shinsaku ^a  

^a OSAKA UNIVERSITY   (Japan)

^b ZHEJIANG UNIVERSITY   (China)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^e KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Anti tumor effect; CCL19; Chemokine; OV HM cell; Recombinant adenovirus vector; XCL1

Indexed keywords

ADENOVIRUS VECTOR; ARGINYLGLYCYLASPARTIC ACID; CHEMOKINE RECEPTOR; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; RECOMBINANT LYMPHOTACTIN; RECOMBINANT MACROPHAGE INFLAMMATORY PROTEIN 3BETA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL MIGRATION; CELL STRAIN OV HM; CHEMOTAXIS; DRUG RESPONSE; FEMALE; FIBER MUTANT ADENOVIRUS VECTOR; GENE CASSETTE; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INBRED MOUSE STRAIN B6C3F1; INBRED STRAIN; MOUSE; MOUSE STRAIN; NONHUMAN; OVARY CARCINOMA; TUMOR MODEL; VIRUS MUTANT; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHEMOKINES, CC; FEMALE; GENETIC VECTORS; HUMANS; MICE; OVARIAN NEOPLASMS; TRANSFECTION;

EID: 21144436810     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1066     Document Type: Article

References (42)

1. Yoshie O., Imai T., Nomiyama H., Adv. Immunol., 78, 57-110 (2001).
2. Baggiolini M., J. Intern. Med., 250, 91-104 (2001).
3. Homey B., Muller A., Zlotnik A., Nat. Rev. Immunol., 2, 175-184 (2002).
4. Wang Q., Yu H., Zhang L., Ju D., Pan J., Xia D., Yao H., Zhang W., Wang J., Cao X., J. Mol. Med., 80, 585-594 (2002).
5. Strieter R. M., Polverini P. J., Arenberg D. A., Walz A., Opdenakker G., Van Damme J., Kunkel S. L., J. Leukoc Biol., 57, 752-762 (1995).
6. Huang S., Xie K., Singh R. K., Gutman M., Bar-eli M., J. Interferon Cytokine Res., 15, 655-665 (1996).
7. Laning J., Kawasaki H., Tanaka E., Luo Y., Dorf M. E., J. Immunol., 153, 4625-4635 (1994).
8. Maric M., Liu Y., Cancer Res., 59, 5549-5553 (1999).
9. Guo J., Wang B., Zhang M., Chen T., Yu Y., Regulier E., Homann H., Qin Z., Ju D. W., Gene Ther., 9, 793-803 (2002).
10. Gao J. Q., Tsuda Y., Katayama K., Nakayama T., Hatanaka Y., Tani Y., Mizuguchi H., Hayakawa T., Yoshie O., Tsutsumi Y., Mayumi T., Nakagawa S., Cancer Res., 63, 4420-4425 (2003).
11. Yoshida R., Nagira M., Imai T., Baba M., Takagi S., Tabira Y., Akagi J., Nomiyama H., Yoshie O., Int. Immunol., 10, 901-910 (1998).
12. Kellermann S. A., Hudak S., Oldham E. R., Liu Y. J., McEvoy L. M., J. Immunol., 162, 3859-3864 (1999).
13. Kennedy J., Kelner G. S., Kleyensteuber S., Schall T. J., Weiss M. C., Yssel H., Schneider P. V., Cocks B. G., Bacon K. B., Zlotnik A., J. Immunol., 155, 203-209 (1995).
14. Giancarlo B., Silvano S., Albert Z., Mantovani A., Allavena P., Eur. J. Immunol., 26, 3238-3241 (1996).
15. St George J. A., Gene Ther., 10, 1135-1141 (2003).
16. Wu H., Han T., Lam J. T., Leath C. A., Dmitriev I., Kashentseva E., Barnes M. N., Alvarez R. D., Curiel D. T., Gene Ther., 11, 874-878 (2004).
17. Okada N., Saito T., Masunaga Y., Tsukada Y., Nakagawa S., Mizuguchi H., Mori K., Okada Y., Fujita T., Hayakawa T., Mayumi T., Yamamoto A., Cancer Res., 61, 7913-7919 (2001).
18. Okada Y., Okada N., Nakagawa S., Mizuguchi H., Kanehira M., Nishino N., Takahashi K., Mizuno K., Hayakawa T., Mayumi T., Cancer Lett., 177, 57-63 (2002).
19. Hashimoto M., Niwa O., Nitta Y., Takeichi M., Yokoro K., Jpn. J. Cancer Res., 80, 459-463 (1989).
20. Mizuguchi H., Kay M. A., Hayakawa T., Biotechniques, 30, 1112-1114 (2001).
21. Mizuguchi H., Koizumi N., Hosono T., Utoguchi N., Watanabe Y., Kay M. A., Hayakawa T., Gene Ther., 8, 730-735 (2001).
22. Mizuguchi H., Kay M. A., Hum. Gene Ther., 9, 2577-2583 (1998).
23. Maizel J. V., Jr., White D. O., Scharff M. D., Virology, 36, 115-125 (1968).
24. Rosenfeld M. A., Siegfried W., Yoshimura K., Yoneyama K., Fukayama M., Stier L. E., Paakko P. K., Gilardi P., Stratfold-Perricaudet L. D., Perricaudet M., Science., 252, 431-434 (1991).
25. Crystal R. G., McElvaney N. G., Rosenfeld M. A., Chu C. S., Mastrangeli A., Hay J. G., Brody S. L., Jaffe H. A., Eissa N. T., Danel C., Nat. Genet., 8, 41-51 (1994).
26. Bergelson J. M., Cunningham J. A., Droguett G., Kurt-Jones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W., Science, 275, 1320-1323 (1997).
27. Tomko R. P., Xu R., Philipson L., Proc. Natl. Acad. Sci. U.S.A., 94, 3352-3356 (1997).
28. Wickham T. J., Mathias P., Cheresh D. A., Nemerow G. R., Cell, 73, 309-319 (1993).
29. Wickham T. J., Filardo E. J., Cheresh D. A., Nemerow G. R., J. Cell Biol., 127, 257-264 (1994).
30. Okada N., Gao J. Q., Sasaki A., Niwa M., Okada Y., Nakayama T., Yoshie O., Mizuguchi H., Hayakawa T., Fujita T., Yamamoto A., Tsutsumi Y., Mayumi T., Nakagawa S., Biochem. Biophy. Res. Commun., 317, 68-76 (2004).
31. Hedrick J. A., Saylor V., Figueroa D., Mizoue L., Xu Y., Menon S., Abrams J., Handel T., Zlotnik A., J. Immunol., 158, 1533-1540 (1997).
32. Nomura T., Hasegawa H., Kohno M., Sasaki M., Fujita S., Int. J. Cancer, 91, 597-606 (2001).
33. Braun S. E., Chen K., Foster R. G., Kim C. H., Hromas R., Kaplan M. H., Broxmeyer H. E., Cornetta K., J. Immunol., 164, 4025-4031 (2000).
34. Hillinger S., Yang S. C., Zhu L., Huang M., Duckett R., Atianzar K., Batra R. K., Strieter R. M., Dubinett S. M., Sharma S., J. Immunol., 171, 6457-6465 (2003).
35. Narvaiza I., Mazzolini G., Barajas M., Duarte M., Zaratiegui M., Qian C., Melero I., Prieto J., J. Immunol., 164, 3112-3122 (2000).
36. Paillard F., Hum. Gene Ther., 10, 695-696 (1999).
37. Ruehlmann J. M., Xiang R., Niethammer A. G., Ba Y., Pertl U., Dolman C. S., Gillies S. D., Reisfeld R. A., Cancer Res., 61, 8498-8503 (2001).
38. Tolba K. A., Bowers W. J., Muller J., Housekneckt V., Giuliano R. E., Federoff H. J., Rosenblatt J. D., Cancer Res., 62, 6545-6551 (2002).
39. Dilloo D., Bacon K., Holden W., Zhong W., Burdach S., Zlotnik A., Brenner M., Nat. Med., 2, 1090-1095 (1996).
40. Emtage P. C., Wan Y., Hitt M., Graham F. L., Muller W. J., Zlotnik A., Gauldie J., Hum. Gene Ther., 10, 697-709 (1999).
41. Cao X., Zhang W., He L., Xie Z., Ma S., Tao Q., Yu Y., Hamada H., Wang J., J. Immunol., 161, 6238-6244 (1998).
42. Huang H., Xiang J., Int. J. Cancer, 109, 817-825 (2004).